Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21869685 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Melatonin for Prevention of Metabolic Side Effects of Olanzapine
Condition: Schizophrenia
Interventions: Drug: Melatonin;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.